Evidence map›Paper›PMID 38990808›Full record

ArticlePloS one2024

Treatment for preschool age children who stutter: Protocol of a randomised, non-inferiority parallel group pragmatic trial with Mini-KIDS, social cognitive behaviour treatment and the Lidcombe Program-TreatPaCS.

Anne-Lise Leclercq, Veerle Waelkens, Ella Roelant, Mathias Allegaert, Iris Verhaegen, Kim Claes, Estelle Dauvister, Steffi Snijders, Kurt Eggers, Astrid Moyse and 1 more

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05185726 (Treatment for Preschool Age Children Who Stutter), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05185726 naunknown statusnot on this map

Treatment for Preschool Age Children Who Stutter: A Randomised, Multicentre, Non-inferiority Parallel Group Pragmatic Trial With Mini-KIDS, the Social Cognitive Behaviour Therapy and the Lidcombe Program With 249 Children

TypeinterventionalSponsorThomas More University of Applied SciencesRan2022 to 2025Enrolled249ConditionsStuttering, DevelopmentalArmsLidcombe Program, Mini-KIDS, Social Cognitive Behavioural Therapy
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anne-Lise LeclercqResearch Unit for a life-Course perspective on Health and Education (RUCHE), University of Liège, Liège, Belgium.
Veerle WaelkensDepartment of Speech and Language Pathology, Artevelde University of Applied Sciences, Ghent, Belgium.ORCID 0009-0000-3212-4882
Ella RoelantClinical Trials Center, Antwerp University Hospital (UZA), Antwerp, Belgium.
Mathias AllegaertClinical Trials Center, Antwerp University Hospital (UZA), Antwerp, Belgium.
Iris VerhaegenClinical Trials Center, Antwerp University Hospital (UZA), Antwerp, Belgium.ORCID 0000-0002-7496-7439
Kim ClaesClinical Trials Center, Antwerp University Hospital (UZA), Antwerp, Belgium.
Estelle DauvisterResearch Unit for a life-Course perspective on Health and Education (RUCHE), University of Liège, Liège, Belgium.
Steffi SnijdersCenter of Expertise Care and Wellbeing, Thomas More University of Applied Sciences, Antwerp, Belgium.ORCID 0000-0003-0988-0326
Kurt EggersCenter of Expertise Care and Wellbeing, Thomas More University of Applied Sciences, Antwerp, Belgium.ORCID 0000-0003-4221-2063
Astrid MoyseResearch Unit for a life-Course perspective on Health and Education (RUCHE), University of Liège, Liège, Belgium.
Sabine Van EerdenbrughCenter of Expertise Care and Wellbeing, Thomas More University of Applied Sciences, Antwerp, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stuttering is a speech disorder in which the flow of speech is disrupted by involuntary repetitions of sounds, syllables, words or phrases, stretched sounds or silent pauses in which the person is unable to produce sounds and sound transitions. Treatment success is the highest if stuttering is treated before the age of 6 years, before it develops into "persistent" stuttering. Stuttering treatment programs that focus directly on the speech of the child, like the Lidcombe Program, have shown to be effective in this age group. Mini-KIDS is also a treatment that focuses directly on the speech of the child. It is possible that capturing the increased brain plasticity at this age in combination with creating optimal conditions for recovery underlie these treatments' success rate. A treatment focusing on the cognitions, emotions and behaviour of the child, the social cognitive behaviour treatment (SCBT), is also frequently delivered in Belgium. In this study we want to compare, and collect data on the effectiveness, of these three treatment programs: Mini-KIDS, SCBT and the Lidcombe Program (protocol registered under number NCT05185726). 249 children will be allocated to one of three treatment groups. Stuttering specialists will treat the child (and guide the parents) with Mini-KIDS, the SCBT or the Lidcombe Program. They will be trained to deliver the programs meticulously. At 18 months after randomisation, the speech fluency of the child and the attitude of the child and parent(s) towards speech will be measured. It is expected that the three programs will achieve the same (near) zero levels of stuttering in nearly all children and a positive attitude towards speech at 18 months after the start of treatment. The amount of treatment hours to reach the (near) zero levels of stuttering will be compared between the different programmes. For families as well as for the health system this could generate important information.

Indexed as

Cognitive Behavioral TherapySpeech TherapyStutteringChildChild, PreschoolEquivalence Trials as TopicFemaleHumansMalePragmatic Clinical Trials as TopicTreatment Outcome

Identifiers

PMID38990808
PMCPMC11239023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.